The New Jersey Chapter's Board of Trustees is comprised of distinguished individuals dedicated to LLS's mission to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
- Mike Shevlin, Microsoft
- Mike Capone, Qlik
- John Hyland, Private Advisor Group
- James Wishbow, James Wishbow & Co.
- Eduardo Schur, Navigant
- Greg Geissman, Bristol Myers Squibb
- Swati Navani, Seattle Genetics
- Dr. Matt Matasar, Memorial Sloan Kettering
- Peter Cordua, HBK CPAs & Consultants
- Chris Pilla, Turtle & Hughes
- Guy Adami, Private Advisor Group
- Lynda Bennett, Lowenstein Sandler
- Todd Levine, Levine Financial
- Dr. Andrew Evens, Rutgers Cancer Institute of New Jersey
- Winselow Tucker, Bristol Myers Squibb